Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Future directions for peptide therapeutics development.

Kaspar AA, Reichert JM.

Drug Discov Today. 2013 Sep;18(17-18):807-17. doi: 10.1016/j.drudis.2013.05.011. Epub 2013 May 28. Review.

PMID:
23726889
2.

A role of the mitochondrial apoptosis-inducing factor in granulysin-induced apoptosis.

Pardo J, Pérez-Galán P, Gamen S, Marzo I, Monleón I, Kaspar AA, Susín SA, Kroemer G, Krensky AM, Naval J, Anel A.

J Immunol. 2001 Aug 1;167(3):1222-9.

3.

A distinct pathway of cell-mediated apoptosis initiated by granulysin.

Kaspar AA, Okada S, Kumar J, Poulain FR, Drouvalakis KA, Kelekar A, Hanson DA, Kluck RM, Hitoshi Y, Johnson DE, Froelich CJ, Thompson CB, Newmeyer DD, Anel A, Clayberger C, Krensky AM.

J Immunol. 2001 Jul 1;167(1):350-6.

4.

Granulysin blocks replication of varicella-zoster virus and triggers apoptosis of infected cells.

Hata A, Zerboni L, Sommer M, Kaspar AA, Clayberger C, Krensky AM, Arvin AM.

Viral Immunol. 2001;14(2):125-33.

PMID:
11398808
5.

Biosynthesis of granulysin, a novel cytolytic molecule.

Hanson DA, Kaspar AA, Poulain FR, Krensky AM.

Mol Immunol. 1999 May;36(7):413-22.

PMID:
10449094
6.

[On processes of adaptation in the auditory analyzer in disorders of the central nervous system].

Zhukovich AV, Kaspar AA.

Vestn Otorinolaringol. 1966 Jan-Feb;28(1):30-7. Russian. No abstract available.

PMID:
5988178
7.

[Treatment of otitis with penicillin].

KASPAR AA.

Feldsher Akush. 1952 May;5:51-2. Undetermined Language. No abstract available.

PMID:
14937053

Supplemental Content

Loading ...
Support Center